Working… Menu

JAK Inhibitor Treatment in AGS

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03921554
Recruitment Status : Recruiting
First Posted : April 19, 2019
Last Update Posted : September 17, 2019
Eli Lilly and Company
Information provided by (Responsible Party):
Adeline Vanderver, MD, Children's Hospital of Philadelphia

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : June 2025
Estimated Study Completion Date : December 2025